"Revolutionizing H.I.V. Care: The Promise of Long-Acting Drugs"
Scientists are developing long-acting drugs for H.I.V. prevention and treatment, including once-weekly pills and semiannual shots, which could revolutionize care for the virus, particularly in hard-to-reach populations. These new regimens may eliminate the need for daily medication, potentially reducing stigma and improving adherence for patients.